Skip to main content

Arnuity Ellipta News

More Kids Without Asthma Inhaler After Flovent Taken Off Market

WEDNESDAY, April 30, 2025 — More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline w...

Timing Might Be Everything With Asthma Inhalers

WEDNESDAY, April 16, 2025 – Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says. A single daily preventive dose of inhaled...

GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age

London, UK 21 May 2018 --GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled...

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD

London UK – 18 September 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single i...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Asthma - Maintenance

Arnuity Ellipta patient information at Drugs.com